Mizuho Securities maintained a Buy rating on NewLink Genetics (NASDAQ: NLNK), and cut the price target to $20.00 (from $52.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Unusual 11 Mid-Day Movers 5/10: (CCXI) (CROX) (SODA) Higher; (EPRS) (NLNK) (JGW) LowerMay 10, 2016 12:50 PM Pre-Open Stock Movers 05/10: (CCXI) (ALXA) (GPRO) Higher; (NLNK) (SCTY) (MNKD) Lower (more...)May 10, 2016 9:36 AM Baird Highlighgs NewLink Genetics' (NLNK) IDO Program Amid Algenpantucel-L FailureMay 10, 2016 6:29 AM After-Hours Stock Movers 05/09: (STMP) (OPK) (HALO) Higher; (NLNK) (GPS) (BLOX) (RAX) Lower (more...)May 9, 2016 6:25 PM NewLink Genetics (NLNK) Phase 3 Study of Algenpantucel-L Did Not Achieve Primary EndpointMay 9, 2016 4:03 PM NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic CancerMay 9, 2016 4:01 PM NewLink Genetics to Present at Bank of America Merrill Lynch Healthcare ConferenceMay 6, 2016 7:00 AM